Singh, D., Smyth, L., Borrill, Z., Sweeney, L., & Tal-Singer, R. (2010). A randomized, placebo-controlled study of the effects of the p38 MAPK inhibitor SB-681323 on blood biomarkers of inflammation in COPD patients. Journal of Clinical Pharmacology, 50(1), 94-100. https://doi.org/10.1177/0091270009347873